<i>L. plantarum</i> and <i>L. lactis</i> as a promising agent in treatment of inflammatory bowel disease and colorectal cancer-Reference-Cited by-同舟云学术

L. plantarum and L. lactis as a promising agent in treatment of inflammatory bowel disease and colorectal cancer

Published:2023-10-26 Issue: Volume: Page:
ISSN:1746-0913
Container-title:Future Microbiology
language:en
Short-container-title:Future Microbiology

Author:

Javid Hossein¹²^ORCID,Oryani Mahsa Akbari³,Akbari Sanaz⁴,Amiriani Taghi⁵,Ravanbakhsh Samaneh⁶,Rezagholinejad Nastaran⁷,Afshari Amir-R⁸,Karimi-Shahri Mehdi³⁹^ORCID

Affiliation:

1. Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, 1313199137, Iran

2. Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, 917966679, Iran

3. Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, 1313199137, Iran

4. Department of Biology, Islamic Azad University, Mashhad Branch, Mashhad, 9133736351, Iran

5. Golestan Research Center of Gastroenterology & Hepatology, Golestan University of Medical Sciences, Gorgan, 4918936316, Iran

6. Biology Expert, Plant Sciences, graduate of Golestan University, Gorgan, 4918936316, Iran

7. Department of Biochemistry, Payame Noor University (PNU), Mashhad, 193954697, Iran

8. Department of Physiology & Pharmacology, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, 9414974877, Iran

9. Department of Pathology, School of Medicine, Gonabad University of Medical Sciences, Gonabad, 9691657678, Iran

Abstract

It has been understood for nearly a century that patients with intestinal inflammatory disease (IBD) have a higher risk of developing colorectal cancer (CRC). Recently, two species of lactic acid bacteria, Lactobacillus plantarum and Lactococcus lactis, have been investigated as therapeutic agents for IBD. These bacteria have been shown to survive gastric transit, to adhere and colonize in the intestinal tract of humans and modulate the intestinal microbiota and immune response. L. plantarum and L. lactis might be used as multifunctional drugs for the treatment of IBD and the prevention or treatment of CRC. This article summarizes current knowledge of L. plantarum and L. lactis as therapeutic and preventative agents for IBD and CRC, respectively.

Publisher

Future Medicine Ltd

Subject

Microbiology (medical),Microbiology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fmb-2023-0076

Reference85 articles.

1. Bacterial membrane vesicles in inflammatory bowel disease

2. Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis

3. A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae

4. Lactic metabolism revisited: metabolism of lactic acid bacteria in food fermentations and food spoilage

5. A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease